Your prescribing provider determines it based on indication, individual factors, and tolerability, informed by clinical literature and FDA labeling where applicable
Injection Site Reactions: Since many GLP-1 medications are administered via injection, some users may experience redness, itching, or discomfort at the injection site
Individual results vary based on baseline metabolism, adherence, and genetic factors
The peptide program is detailed on the advanced peptide therapy page
Licensed 503A compounding pharmacies entered the market in 20232024 to address access gaps and cost barriers, enabling patients to obtain compounded semaglutide and tirzepatide without insurance or membership requirementspricing that is $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutide injection